Toggle light / dark theme

Scientists shed new light on the shared genetic basis of psychiatric disorders

New research uncovers how shared genes contribute to various psychiatric disorders. This breakthrough highlights the importance of pleiotropic genes—those affecting multiple conditions—and offers new avenues for mental health treatment development.

Children with better musical skills may benefit from a prolonged window of brain plasticity

Children who excel at keeping the beat may possess brains that mature more slowly, extending their capacity for learning. A new longitudinal twin study indicates that this prolonged development is shaped by both genetic predispositions and musical engagement.

CSF α-Synuclein Seed Amplification Assays and Alzheimer Disease Biomarkers in Dementia With Lewy BodiesPresentation and Progression

CSF α-Synuclein Seed Amplification Assays and Alzheimer Disease Biomarkers in Dementia With Lewy Bodies: Presentation and Progression.

Neuroimmune Interactions: From the Brain to the Immune System and Vice Versa

In line with the original observation by Selye of an involution of the thymus and other lymphoid organs in response to stress (205) and the subsequent demonstration of the immunosuppressive effects of glucocorticoids (101), glucocorticoids have traditionally been seen as the hormonal mediators of the immunosuppressive effects of stressors. We will not delve into the details of the vast literature on the effects of stress on immunity, as this topic has been reviewed on several occasions and it is not directly relevant to the present review (3, 9, 160, 169, 204, 220).

Glucocorticoids act on their cellular targets by binding to glucocorticoid receptors (GRs). GRs normally reside in the cytosol in the form of a protein complex that brings together heat-shock proteins and FK506 binding protein 52. Upon binding to their ligand, GRs dissociate from this complex to form monomers or dimers and translocate to the nucleus The anti-inflammatory effects of glucocorticoids are mediated by transcriptional repression following nuclear translocation and tethering of monomeric GRs to the glucocorticoid-response elements of transcription factors such as NF-κB, activator protein (AP)-1, and IFN-regulating factor-3 (234). This results in the downregulation of genes coding for inflammatory mediators, enzymes, and adhesion molecules. Although the hypothesis is still controversial, GR dimerization and transactivation are thought to play an important role in the anti-inflammatory activity of glucocorticoids. This phenomenon is illustrated by data obtained in GR(dim/dim) mutant mice that show reduced GR dimerization and increased sensitivity to TNF-induced inflammation, and to experimental models of sepsis induced by LPS or cecal ligation and puncture (123, 235).

Glucocorticoids can be proinflammatory under certain conditions. This effect can be secondary to the selection of corticoid-resistant inflammatory cells, such as pathogenic Th17 cells that overexpress IL-23 receptor and multidrug-resistance protein and that are found in inflamed gut tissue from patients with Crohn’s disease (186). The proinflammatory effect of glucocorticoids may also result from inhibition of the production and release of anti-inflammatory factors, or conversely from enhanced production and release of proinflammatory mediators. In the first case, dexamethasone administered 24 h before LPS was found to enhance the placenta’s proinflammatory cytokine response to LPS as a consequence of the inhibition of lipoxin A4 synthesis (255). In the second case, it is the dose of glucocorticoids that makes the difference: as mentioned above, physiological glucocorticoid levels can be proinflammatory in some circumstances, whereas high or pharmacological levels are anti-inflammatory. For instance, low doses of glucocorticoids increase the production of macrophage migration inhibitory factor, and this effect is sufficient to override glucocorticoid-mediated inhibition of cytokine production and release by LPS-stimulated monocytes (39).

Study maps how psilocybin reshapes brain circuits linked to depression

An international collaboration led by Cornell researchers used a combination of psilocybin and the rabies virus to map how—and where—the psychedelic compound rewires the connections in the brain.

Specifically, they showed psilocybin weakens the cortico-cortical feedback loops that can lock people into negative thinking. Psilocybin also strengthens pathways to subcortical regions that turn sensory perceptions into action, essentially enhancing sensory-motor responses.

The findings were published Dec. 5 in Cell. The lead author is postdoctoral researcher Quan Jiang.

Poor kidney health linked to higher levels of Alzheimer’s biomarkers in blood

People with impaired kidney function have higher levels of Alzheimer’s biomarkers in their blood, but not an increased risk of dementia, according to a study published in Neurology.

The study does not prove that poor kidney function causes higher levels of Alzheimer’s biomarkers in the blood, it only shows an association.

Kidneys remove waste and toxins from the blood, which are then excreted in urine.

Miniature microscope captures real-time voltage signals in awake animals

Researchers have built a tiny, lightweight microscope that captures neuron activity with unprecedented speed that can be used in freely moving animals. The new tool could give scientists a more complete view of how brain cells process information during natural behavior.

The microscope is designed to image genetically encoded voltage indicators —fluorescent dyes that rapidly change brightness when a neuron fires—through a small window in the skull while the animal is awake.

“Unlike most miniature microscopes that track slower calcium signals, ours captures electrical spikes at hundreds of frames per second,” said Emily Gibson from the University of Colorado Anschutz Medical Campus. “This makes it possible to capture the moment a neuron fires as well as the quieter signals that build up inside neurons before firing.”

/* */